Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 431, doi. 10.1016/j.molonc.2013.11.010
- By:
- Publication type:
- Article
Works matching IS 15747891 AND DT 2014 AND VI 8 AND IP 2
Results: 23
1
2
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 417, doi. 10.1016/j.molonc.2013.12.010
- By:
- Publication type:
- Article
3
LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 401, doi. 10.1016/j.molonc.2013.12.009
- By:
- Publication type:
- Article
4
PELP1 oncogenic functions involve alternative splicing via PRMT6.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 389, doi. 10.1016/j.molonc.2013.12.012
- By:
- Publication type:
- Article
5
An ‘in-cell trial’ to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 378, doi. 10.1016/j.molonc.2013.12.006
- By:
- Publication type:
- Article
6
SERPINA5 inhibits tumor cell migration by modulating the fibronectin–integrin β1 signaling pathway in hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 366, doi. 10.1016/j.molonc.2013.12.003
- By:
- Publication type:
- Article
7
Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 351, doi. 10.1016/j.molonc.2013.11.009
- By:
- Publication type:
- Article
8
The carcinoembryonic antigen IgV-like N domain plays a critical role in the implantation of metastatic tumor cells.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 337, doi. 10.1016/j.molonc.2013.12.002
- By:
- Publication type:
- Article
9
Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 323, doi. 10.1016/j.molonc.2013.12.005
- By:
- Publication type:
- Article
10
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 311, doi. 10.1016/j.molonc.2013.12.004
- By:
- Publication type:
- Article
11
Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 297, doi. 10.1016/j.molonc.2013.12.001
- By:
- Publication type:
- Article
12
SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 285, doi. 10.1016/j.molonc.2013.11.006
- By:
- Publication type:
- Article
13
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 273, doi. 10.1016/j.molonc.2013.11.008
- By:
- Publication type:
- Article
14
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 261, doi. 10.1016/j.molonc.2013.11.007
- By:
- Publication type:
- Article
15
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 250, doi. 10.1016/j.molonc.2013.11.005
- By:
- Publication type:
- Article
16
pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 232, doi. 10.1016/j.molonc.2013.11.003
- By:
- Publication type:
- Article
17
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 221, doi. 10.1016/j.molonc.2013.11.004
- By:
- Publication type:
- Article
18
Pharmacologic inhibition of vacuolar H+ ATPase reduces physiologic and oncogenic Notch signaling.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 207, doi. 10.1016/j.molonc.2013.11.002
- By:
- Publication type:
- Article
19
RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 196, doi. 10.1016/j.molonc.2013.11.001
- By:
- Publication type:
- Article
20
Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 178, doi. 10.1016/j.molonc.2013.10.008
- By:
- Publication type:
- Article
21
Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, Apc <sup> Min/+ </sup> mice.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 169, doi. 10.1016/j.molonc.2013.10.009
- By:
- Publication type:
- Article
22
Chromosome instability and carcinogenesis: Insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 161, doi. 10.1016/j.molonc.2013.10.005
- By:
- Publication type:
- Article
23
Editorial Board.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. ii, doi. 10.1016/S1574-7891(14)00030-1
- Publication type:
- Article